Artelo Biosciences

Yahoo Finance • 13 days ago

Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

SOLANA BEACH, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) today announced the closing of its previously announced private placement of 3,188,407 shares of common stock (or pre-funded warrant in lieu... Full story

Yahoo Finance • 18 days ago

Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength

BRISTOL, Tenn., March 25, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL) is drawing increased attention following its expansion into the $16.3 billion glaucoma market through a fully funded investigator-sponsored clinic... Full story

Yahoo Finance • 25 days ago

Biotech Breakthroughs and Strategic Pivots Fuel Market Momentum

DENVER, March 18, 2026 (GLOBE NEWSWIRE) -- Today’s action highlights biotech and healthcare innovators advancing novel therapies and strategic platforms amid rising demand for targeted treatments and efficient global access. With the bio... Full story

Yahoo Finance • 25 days ago

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Li Bang International Corporat 715,505,563 0.11 0.0716 0.0779 +0.0472 YY... Full story

Yahoo Finance • last month

Artelo Biosciences announces 3-for-1 reverse stock split

Artelo Biosciences (ARTL) announced that on February 27, 2026, Artelo’s Board of Directors approved a 3-for-1 reverse stock split of the Company’s common stock. The Company’s common shares will begin trading on a split-adjusted basis on th... Full story

Yahoo Finance • last month

Artelo Biosciences Announces Reverse Stock Split

SOLANA BEACH, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments fo... Full story

Yahoo Finance • 4 months ago

Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical Models

SOLANA BEACH, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for... Full story

Yahoo Finance • 5 months ago

Artelo Biosciences GAAP EPS of $3.97

* Artelo Biosciences press release [https://seekingalpha.com/pr/20303587-artelo-biosciences-provides-business-update-and-reports-third-quarter-2025-financial-results] (ARTL [https://seekingalpha.com/symbol/ARTL]): Q3 GAAP EPS of $3.97.... Full story

Yahoo Finance • 6 months ago

Artelo Biosciences Announces Expanded Clinical Data to be Presented on both ART26.12 and ART27.13 at the 8th Annual Cannabinoid & Endocannabinoid Drug Development Summit

ART26.12 Phase 1 Data Demonstrated No Safety Concerns, Predictable Linear Plasma Exposure, and Options for Dosing in Either Fed or Fasted Conditions ART27.13 Interim Phase 2 Data Showed Substantial Weight Gain and Activity Improvements in... Full story

Yahoo Finance • 6 months ago

Artelo Biosciences Announces Closing of $2.0 Million Public Offering

SOLANA BEACH, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer,... Full story

Yahoo Finance • 6 months ago

Artelo Biosciences launches underwritten public offering to raise capital

Artelo Biosciences (NASDAQ:ARTL [https://seekingalpha.com/symbol/ARTL]) has commenced an underwritten public offering [https://seekingalpha.com/pr/20248127-artelo-biosciences-announces-proposed-underwritten-public-offering] of its common s... Full story

Yahoo Finance • 6 months ago

Artelo Biosciences Announces Proposed Underwritten Public Offering

SOLANA BEACH, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer,... Full story

Yahoo Finance • 7 months ago

Artelo Biosciences Announces Publication of Preclinical Data Demonstrating Superior Efficacy and Bioavailability of ART12.11 in Reducing Stress-Induced Depression and Anxiety Symptoms

SOLANA BEACH, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer,... Full story

Yahoo Finance • 7 months ago

Artelo Biosciences Announces Closing of $3.0 Million Public Offering

SOLANA BEACH, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer,... Full story

Yahoo Finance • 7 months ago

Let's take a look at the stocks that are in motion in today's session.

Curious about what's happening in today's session? Check out the latest stock movements and price changes. [topmovers] TOP GAINERS TICKER CHANGE COMMENT CIGL [https://www.chartmill.com/stock/quote/CIGL/profile] 91.84% CON... Full story

Yahoo Finance • 7 months ago

Top stock movements in today's session.

Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. [topmovers] GAINERS TICKER CHANGE COMMENT CIGL [ht... Full story

Yahoo Finance • 7 months ago

Which stocks are gapping on Thursday?

In today's session, there are notable price gaps in the US markets on Thursday. Take a closer look at the stocks that are gap up and gap down. [gap] TOP GAP UP STOCKS TICKER CHANGE COMMENT CIGL [https://www.chartmill.com/stoc... Full story

Yahoo Finance • 7 months ago

Artelo Biosciences Announces Pricing of $3.0 Million Public Offering

SOLANA BEACH, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer,... Full story

Yahoo Finance • 7 months ago

Top movers in Thursday's pre-market session

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. [premarket] GAINERS TICKER CHANGE COMMENT BRIA [https://www.chartmill.com/st... Full story

Yahoo Finance • 7 months ago

Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS Results

SOLANA BEACH, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer,... Full story